Article
Iguratimod Inhibits the Aggressiveness of Rheumatoid Fibroblast-Like Synoviocytes
14 Nov 2019
Abstract excerpt
Objective . Iguratimod, a novel disease-modifying anti-rheumatic drug for the treatment of rheumatoid arthritis, has been approved in China and Japan. Here, we aimed to find whether iguratimod can inhibit the aggressive behavior and promote apoptosis of rheumatoid fibroblast-like synoviocytes (RA-FLSs). Methods . The proliferation of RA-FLSs was assessed by 5-ethynyl-2 ′ -deoxyuridine test and Cell Counting...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
